Dear Gloucestershire Health and Care NHS Foundation Trust,
1. Do you have a Urology department who see suspected prostate cancer patients referred from the community?
2. What criteria are used to triage (Accept or Reject) referrals from the community, for patients with suspected prostate cancer, including Prostate Specific Antigen (PSA) thresholds and Digital Rectal Examination (DRE) for asymptomatic patients? Please include specific PSA levels used as well as any other criteria
3. What criteria are used to triage (Accept or Reject) referrals from the community, for patients with suspected prostate cancer, including PSA thresholds and DRE for symptomatic patients? Please include specific PSA levels used as well as any other criteria
4. How does your service define symptomatic and asymptomatic for suspected prostate cancer referrals?
5. Do you apply different thresholds or criteria for higher-risk groups (e.g. Black men, men with family history)?
6. For the calendar year 2025:
a. How many patients were referred on the suspected prostate cancer pathway?
b. Of these, how many were classified by the referrer (or by your triage) as asymptomatic?
c. How many were classified as symptomatic?
7. For the same period, how many referred patients had their 2WW referral rejected? Please break this down, if possible, by:
a) Asymptomatic vs symptomatic
b) Rejected primarily due to PSA level below threshold
8. Please provide a copy of your suspected prostate cancer referral form for both asymptomatic and symptomatic patients?
Yours faithfully,

